Clinical Trials Directory

Trials / Completed

CompletedNCT01856452

Comparison Study of Sentinel Lymph Node Biopsy by Multimodal Method in Breast Cancer

Phase II Study of Comparison of Sentinel Lymph Node Biopsy Guided by The Multimodal Method of Indocyanine Green Fluorescence, Radioisotope and Blue Dye Versus the Radioisotope in Breast Cancer

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
86 (actual)
Sponsor
National Cancer Center, Korea · Other Government
Sex
Female
Age
20 Years
Healthy volunteers
Accepted

Summary

Sentinel lymph node biopsy (SLNB) has become a mainstay surgery method in breast cancer. It provides the surgeon the evidence of axillary lymph node metastasis, which determines the extent of surgery. Because effective SLNB can decrease the extent of axillary lymph node dissection, it is increasingly important. In general, radioactive colloid has been used for SLNB. In order to pursue more precise SLNB, the investigators developed a multimodal method enabling visual guidance with the mixture of indocyanine green, blue dye and radioisotope. In this study, our hypotheses are as following: 1. Multimodal method enables to increase identification rate of SLNB 2. blue dye and indocyanine green provide the surgeon visual guidance to ensure better outcome 3. Multimodal method alleviates the shortcomings of indocyanine green and blue dye as an identification strategy

Detailed description

Indocyanine green Advantages: provides visualization of sentinel lymph node without incision Blue dye Advantages: easy to employ; no toxicity Disadvantages: diffusion; absorption and disappearance of the marking within minutes Radioisotope Advantages: can be used for lesions not accessible to Ultrasound; ideal for selective uptake to sentinel lymph node Disadvantages: not able to use palpation and visualization, confirms by gamma-probe only

Conditions

Interventions

TypeNameDescription
DEVICEthe mixture including indocyanine greenSentinel lymph node biopsy using near-infrared imaging system and gamma probe detector for the mixture of indocyanine green, blue dye, and radioisotope during operation
DEVICEradioisotopeSentinel lymph node biopsy using gamma probe detector for radioisotope during operation

Timeline

Start date
2011-09-01
Primary completion
2012-10-01
Completion
2012-10-01
First posted
2013-05-17
Last updated
2013-05-17

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01856452. Inclusion in this directory is not an endorsement.